The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | Causes & management of renal impairment in patients with multiple myeloma
Ravi Vij, MD, MBA, Washington University Medical School, St. Louis, MO, discusses the causes of renal insufficiency in patients with multiple myeloma, commenting on the optimal management of these patients. According to Prof. Vij, it is important to treat patients with therapies that allow them to recover renal function early in order to ensure better long-term outcomes. In addition, Prof. Vij notes that whilst patients can be treated with existing anti-myeloma therapies, they may require dose reductions. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
